Odyssey Health, Inc. (ODYY) Taps Military Advisors to

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
218
Odyssey Health, Inc. (ODYY) Taps Military Advisors to Address Target Market for PRV-002 Concussion Drug

- Odyssey Health is a medical company focused on developing medical products for conditions with unmet needs, one of which is concussion
- Currently, concussions do not have an FDA-approved treatment
- Soldiers form a significant population of people who frequently experience multiple concussions throughout their career
- Concussion has only recently received greater attention as different parties seek to understand the condition and possible treatments
- Odyssey is at the forefront of this pursuit for treatment and has developed the PRV-002 drug candidate that it intends to use on the military as part of a Phase II clinical trial
- The company announced the formation of a Military Advisory Board to help in this journey

According to a study by the Business Development Bank of Canada (“BDC”), 86% of businesses with an advisory board say it has had a substantial impact on their operations. In addition, the study showed that companies with an advisory board witnessed 24% higher annual sales and 18% higher productivity than businesses without one (https://nnw.fm/Dsi6P ).

Looking to tap into these favorable statistics as well as to better understand one of its important target markets, the military, Odyssey Health (OTC: ODYY), a medical company focused on unique, life-saving medical products that offer clinical advantages to conditions with unmet needs, announced the formation of a Military Advisory Board (https://nnw.fm/Iv4Jb ).

The board, which comprises associated military contacts (retired members of the U.S. armed forces who previously held leadership positions), was formed to gain experience and information that will provide crucial insights into traumatic brain injuries (“TBI”) and their effects on those who sustain TBI.

“TBI in general, and mild TBI in particular, is considered a ‘silent epidemic’ because many of the acute and enduring alterations in cognitive, motor, and somatosensory functions may not be readily apparent to external observers,” an article published in the National Institutes of Health (“NIH”)’s National Library of Medicine website reads (https://nnw.fm/unCm8). The article goes on to note that approximately 80% of all TBI cases are categorized as mild (“mTBI”). Still, these approximations are considered underestimates “because they do not account for incidents of TBI in which the person does not seek medical care.”

Concussions are frequent in contact sports, with soldiers making up another significant proportion of people who frequently sustain these injuries multiple times over their careers. Latest statistics show that over 430,000 U.S. service members were diagnosed with a TBI from 2000 to 2020 (https://nnw.fm/7mXbQ ), with 75-83% of these cases having been categorized as mild (“mTBI”) (https://nnw.fm/nabGZ ). In addition, one analysis notes that one in six soldiers returning from deployment in Iraq met the criteria for concussion.

For a long time, however, concussions did not receive the necessary urgency and attention to understand the underlying mechanisms of mild brain trauma and device potential therapeutic interventions. In fact, a New York Times article notes, many soldiers used to shrug off ailments that began following blasts – headaches, dizzy spells, numbness in their arms, dehydration, fatigue, and persistent ringing in their ears – only to later develop even more severe symptoms a few years after the explosions (https://nnw.fm/5fXdb ). But Odyssey is now spearheading efforts to understand the condition and develop treatments for concussion, which until now, does not have an FDA-approved drug.

Odyssey is developing the PRV-002, a novel compound for the treatment of concussion. The drug is currently undergoing evaluations as part of a Phase I clinical trial. Upon completing the Phase 1 trial, presenting its findings to the FDA for review, and after receiving positive feedback, Odyssey intends to initiate a Phase II clinical trial in the U.S., starting with the military. This is where the Military Advisory Board will play a crucial role.

The board comprises Major General USA (r) and Former Chief of Staff USSOCOM James Linder, Commanding General U.S. Army Special Operations Command (r) Francis Beaudette, Lieutenant Colonel (r) Paul Toolan, and Vice Admiral (r) Timothy Szymanski, leaders who understand firsthand the consequences of TBI on the battlefield as well as its impacts on retired and separated service members. They equally recognize the role leaders at all levels have to play to protect the comprehensive brain health of their soldiers and the underlying need to passionately and aggressively pursue treatment.

“Too many service members and veterans are suffering from post-concussive events, while their families are suffering as they watch and provide care. There remains an urgent need for a concussion treatment at the point of injury that immediately treats the initial injury, speeds recovery, and potentially diminishes its long-term effects. We are obligated to pursue treatments that improve a service member’s, and their families’, well-being through their service commitment and beyond,” commented Vice Admiral (r) Timothy Szymanski (https://nnw.fm/HUUR9 ).

For more information, visit the company’s website at https://odysseygi.com/.

NOTE TO INVESTORS: The latest news and updates relating to ODYY are available in the company’s newsroom at https://nnw.fm/ODYY

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Odyssey Group Intl Inc (ODYY) Stock Research Links

ODYY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mercari and Suruga-ya Forge U.S. Venture for Culture

Updated Category News Views 13

Japanese Pop Culture Gears Up for US Market Surge Alright, folks, what we’ve got here is another bold move in the cross-border e-commerce game. Mercari and Suruga-ya are teaming up to establish a joint venture over in the U.S. The goal? To further capitalize on the growing appetite for Japanese entertainment and hobby goods among us all stateside. Now, it’s no secret...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 370

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 348

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Envision and Tsinghua Propel Climate Innovation at COP31

Updated Category News Views 26

Collaborating for a Greener Future On the bustling stage of COP31 in Antalya, Turkey, Envision Energy and Tsinghua University teamed up with the Global Alliance of Universities on Climate (GAUC) to showcase a bold agenda. Their focus transcends mere dialogue, pushing for actionable climate solutions anchored in technological innovation, academic synergy, and the dynamism...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 300

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
LONGi's Four Paths to Global Green Development

Updated Category News Views 79

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 344

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 70

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 45

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 28

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading

Top 5 Most Recently Viewed Articles

TuHURA Biosciences to Showcase Innovations at Major Investment Event

Updated Category News Views 109

TuHURA Biosciences to Present at Investment Conference TuHURA Biosciences, Inc. (NASDAQ: HURA), a pioneering Phase 3 immune-oncology company at the forefront of developing innovative therapeutics, has announced a significant presentation in the investment world. Management is set to showcase their work at the 27th Annual H.C. Wainwright Global Investment Conference, an...

Continue Reading
PennantPark Investment Corporation Enhances CLO Management Strategy

Updated Category News Views 123

PennantPark Investment Corporation Expands CLO Platform MIAMI — PennantPark Investment Corporation (the “Company”) (NYSE: PNNT) has successfully established a strong foothold in the middle market with the recent closing of a $400.5 million debt securitization through its joint venture, PennantPark Senior Loan Fund, LLC ("PSLF"). This significant achievement is part...

Continue Reading
Freeport-McMoRan Exceeds Earnings Expectations Amid Rising Copper Prices

Updated Category News Views 50

Freeport-McMoRan Exceeds Earnings Estimates In a recent financial report, Freeport-McMoRan (NYSE: FCX) showcased its ability to navigate the dynamic mining landscape, particularly benefitting from the surge in copper prices. The company announced a substantial profit that surpassed third-quarter expectations, drawing significant attention from investors and analysts...

Continue Reading
WellsCare and Celltrion Canada Unite for Pain Relief Solutions

Updated Category News Views 126

WellsCare Expands Reach with Celltrion Partnership WellsCare, a pioneering medical technology startup based in South Korea, has forged a promising alliance with Celltrion Canada, a renowned subsidiary of global biopharmaceutical giant Celltrion. This collaboration marks a significant milestone in the development of advanced wearable technology aimed at offering effective...

Continue Reading
Elon Musk Addresses Violence Concerns Amid Political Tensions

Updated Category News Views 524

Elon Musk Issues Stark Warning on Violence at Rally Elon Musk stirred significant debate after his virtual appearance at a far-right rally in the UK, where he alerted attendees to an impending threat of violence. His stark statement, "violence is coming, fight back, or die," has reverberated through political discussions and media outlets alike. Details of the Rally...

Continue Reading